Lindbrook Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.15K | Buy |
274
+58
| +27% | +$454 | ﹤0.01% | 2265 |
|
|
2024
Q4 | $2.27K | Buy |
216
+118
| +120% | +$1.24K | ﹤0.01% | 2274 |
|
|
2024
Q3 | $1.29K | Hold |
98
| – | – | ﹤0.01% | 2452 |
|
|
2024
Q2 | $1.38K | Hold |
98
| – | – | ﹤0.01% | 2439 |
|
|
2024
Q1 | $1.66K | Hold |
98
| – | – | ﹤0.01% | 2306 |
|
|
2023
Q4 | $1.38K | Hold |
98
| – | – | ﹤0.01% | 2387 |
|
|
2023
Q3 | $1.01K | Hold |
98
| – | – | ﹤0.01% | 2358 |
|
|
2023
Q2 | $1.62K | Sell |
98
-2,000
| -95% | -$33K | ﹤0.01% | 2232 |
|
|
2023
Q1 | $19.2K | Buy |
2,098
+200
| +11% | +$1.83K | ﹤0.01% | 1096 |
|
|
2022
Q4 | $13.6K | Sell |
1,898
-188
| -9% | -$1.35K | ﹤0.01% | 1278 |
|
|
2022
Q3 | $10K | Buy |
2,086
+286
| +16% | +$1.37K | ﹤0.01% | 1309 |
|
|
2022
Q2 | $4K | Buy |
+1,800
| New | +$4K | ﹤0.01% | 1612 |
|